Exela Technologies, Inc. (“Exela” or the “Company”) (NASDAQ: XELA,
XELAP), a global business process automation (“BPA”) leader,
announced today its financial results for the third quarter ended
September 30, 2022.
“Since stepping into my current role over a year
ago, we have completed many of the objectives laid out; however,
our intrinsic value remains deeply discounted. Our business is
positioned for operational leverage with conversion of the pipeline
into contract wins, stable renewals, and significant operational
improvements. In light of the macro environment, we are focused on
converting actions into results,” said Par Chadha, Executive
Chairman of Exela.
Third Quarter Business
Highlights
- Exela’s European business signed a
deal to go public through a merger with CF Acquisition Corp. VIII
based on a $220 million valuation. Exela will be the majority owner
of the merged public company
- Exela Technologies, Inc.
subsidiaries own $298M principal amount of the 2026 Senior Notes
issued by Exela Intermediate, LLC
- Revenue lower by $15.2M due to
network outage, currency translation, transition revenue(3), other
customer losses and tight job markets
- Strategic decision to adopt work
from anywhere model is reaching inflection; approximately $40.5M in
operational improvements estimated in 2023
- Won $87M TCV in Q3; record YTD in
new business wins
- Digital Asset platforms DMR grew
227% and DrySign® 1,244% over Q3 2021
- Eliminated over $163M in
liabilities due in 2022; Revolver and Appraisal Action payoff
completed in Q3
Third Quarter
Highlights
- Revenue: Revenue
for Q3 2022 was $264.0 million, a decline of 5.4% compared to
$279.2 million in Q3 2021.
- Revenue for the Information and
Transaction Processing Solutions (“ITPS”) segment was $185.3
million, a decline of 11% year-over-year, primarily due to network
outage impacting contracted revenues(4), currency translation,
transition revenue and staffing shortages.
- Healthcare Solutions revenue was
$61.0 million, an increase of 13.0% year-over-year, led by
continuing acceptance of our solutions and services.
- Legal and Loss Prevention Services
revenue was $17.8 million, an increase of 5.3% year-over-year.
Operating
income/loss:
Operating loss for Q3 2022 was $47.5 million, compared with
operating income of $2.4 million in Q3 2021. The year over year
change was due to the gross profit decline of $21.3 million and
goodwill impairment charge of $29.6 million.
- Net Loss: Net loss
for Q3 2022 was $85.3 million, compared with a net loss of $13.2
million in Q3 2021. In addition to the changes in the operating
loss and goodwill impairment, the year over year increase in net
loss was due to a $23.4 million decline in non-cash debt
modification and extinguishment gain.
-
EBITDA(5):
EBITDA for Q3 2022 was ($24.7) million compared to $49.1 million in
Q3 2021. EBITDA margin for Q3 2022 was (9.4%) compared to 17.6% in
Q3 2021.
- Adjusted
EBITDA(6):
Adjusted EBITDA for Q3 2022 was $31.8 million, a decrease of 12.5%
compared to $36.4 million in Q3 2021. Adjusted EBITDA margin for Q3
2022 was 12.1%, a decrease of 98 basis points from 13.0% in Q3 2021
and down from 13.7% in Q2 2022.
- Capital
Expenditures: Capital expenditures for Q3 2022 were 1.7%
of revenue compared to 1.3% of revenue in Q3 2021.
Maintaining financial
flexibility: Raised a total of $67.6
million in gross proceeds from equity offerings in Q3 2022. Total
debt(7) increased by $18.6 million compared to Q2 2022.
Below are the notes referenced above:(1) Total
Contract Value(2) Digital Mailroom(3) Represents revenue from
exiting contracts and statements of work with certain customers
that we believe was unpredictable, non-recurring and were not a
strategic fit to the Company’s long-term success or unlikely to
achieve the Company’s long-term target margins.(4) In late June
2022, the Company experienced a network security incident impacting
certain of the Company’s operational and information technology
systems. The Company immediately took steps to isolate the impact
and prevent additional systems from being affected, including
taking large parts of its network offline as a precaution and
thereby disrupting some access to our applications and services by
our employees and customers. The Company’s systems recovery efforts
are complete, and the Company’s operations are fully functional,
however, the incident did result in some loss of revenue in the end
of the second quarter and in the third quarter as well as certain
incremental costs, some of which is expected to continue.(5) EBITDA
is a non-GAAP measure. A reconciliation of EBITDA to Net Loss
determined in accordance with GAAP is attached to this release.(6)
Adjusted EBITDA is a non-GAAP measure. A reconciliation of Adjusted
EBITDA to Net Loss determined in accordance with GAAP is attached
to this release.(7) Total debt includes all long-term debt and
interest-bearing current liabilities
Earnings Conference Call and Audio
WebcastExela will host a conference call to discuss its
third quarter 2022 financial results at 6:00 PM ET on November 14,
2022. To access this call, dial 833-255-2831 or
+1-412-902-6724 (international).
A replay will be available through November 21, 2022 at
877-344-7529 or +1-412-317-0088 (international). The replay
passcode is 7071365. A replay will also be archived on the
Exela investor relations website at
http://investors.exelatech.com.
Exela invites all investors to ask questions
that they would like addressed on the conference call. We ask
investors to submit questions via email to IR@exelatech.com.
A live webcast of this conference call will be
available on the “Investors” page of the Company’s website
(www.exelatech.com). A supplemental slide presentation that
accompanies this call and webcast can be found on the investor
relations website (http://investors.exelatech.com/) and will remain
available after the call.
About Exela Exela Technologies
is a business process automation (BPA) leader, leveraging a global
footprint and proprietary technology to provide digital
transformation solutions enhancing quality, productivity, and
end-user experience. With decades of experience operating
mission-critical processes, Exela serves a growing roster of more
than 4,000 customers throughout 50 countries, including over 60% of
the Fortune® 100. Utilizing foundational technologies spanning
information management, workflow automation, and integrated
communications, Exela’s software and services include
multi-industry, departmental solution suites addressing finance and
accounting, human capital management, and legal management, as well
as industry-specific solutions for banking, healthcare, insurance,
and the public sector. Through cloud-enabled platforms, built on a
configurable stack of automation modules, and approximately 16,500
employees operating in 21 countries, Exela rapidly deploys
integrated technology and operations as an end-to-end digital
journey partner.
Find out more at www.exelatech.com
To automatically receive Exela financial news by e-mail, please
visit the Exela Investor Relations website,
http://investors.exelatech.com/, and subscribe to E-mail
Alerts.
About Non-GAAP Financial Measures: This press
release includes constant currency, EBITDA and Adjusted EBITDA,
each of which is a financial measure that is not prepared in
accordance with U.S. generally accepted accounting principles
(“GAAP”). Exela believes that the presentation of these non-GAAP
financial measures will provide useful information to investors in
assessing our financial performance, results of operations and
liquidity and allows investors to better understand the trends in
our business and to better understand and compare our results.
Exela’s board of directors and management use constant currency,
EBITDA and Adjusted EBITDA to assess Exela’s financial performance,
because it allows them to compare Exela’s operating performance on
a consistent basis across periods by removing the effects of
Exela’s capital structure (such as varying levels of debt and
interest expense, as well as transaction costs resulting from the
combination of Quinpario Acquisition Corp. 2, SourceHOV Holdings,
Inc. and Novitex Holdings, Inc. on July 12, 2017 (the “Novitex
Business Combination”) and capital markets-based activities).
Adjusted EBITDA also seeks to remove the effects
of integration and related costs to achieve the savings,
any expected reduction in operating expenses due to the Novitex
Business Combination, asset base (such as depreciation and
amortization) and other similar non-routine items outside the
control of our management team. Optimization and
restructuring expenses and merger adjustments are primarily related
to the implementation of strategic actions and initiatives related
to the Novitex Business Combination. All of these costs are
variable and dependent upon the nature of the actions being
implemented and can vary significantly driven by business needs.
Accordingly, due to that significant variability, we exclude these
charges since we do not believe they truly reflect our past,
current or future operating performance. The constant currency
presentation excludes the impact of fluctuations in foreign
currency exchange rates. We calculate constant currency revenue and
Adjusted EBITDA on a constant currency basis by converting our
current-period local currency financial results using the exchange
rates from the corresponding prior-period and compare these
adjusted amounts to our corresponding prior period reported
results. Exela does not consider these non-GAAP measures in
isolation or as an alternative to liquidity or financial measures
determined in accordance with GAAP. A limitation of these non-GAAP
financial measures is that they exclude significant expenses and
income that are required by GAAP to be recorded in Exela’s
financial statements. In addition, they are subject to inherent
limitations as they reflect the exercise of judgments by management
about which expenses and income are excluded or included in
determining these non-GAAP financial measures and therefore the
basis of presentation for these measures may not be comparable to
similarly-titled measures used by other companies. These non-GAAP
financial measures are not required to be uniformly applied, are
not audited and should not be considered in isolation or as
substitutes for results prepared in accordance with GAAP. Net loss
is the GAAP measure most directly comparable to the non-GAAP
measures presented here. For reconciliation of the comparable GAAP
measures to these non-GAAP financial measures, see the schedules
attached to this release.
Forward-Looking Statements:
Certain statements included in this press release are not
historical facts but are forward-looking statements for purposes of
the safe harbor provisions under The Private Securities Litigation
Reform Act of 1995. Forward-looking statements generally are
accompanied by words such as “may”, “should”, “would”, “plan”,
“intend”, “anticipate”, “believe”, “estimate”, “predict”,
“potential”, “seem”, “seek”, “continue”, “future”, “will”,
“expect”, “outlook” or other similar words, phrases or expressions.
These forward-looking statements include statements regarding our
industry, future events, estimated or anticipated future results
and benefits, future opportunities for Exela, and other statements
that are not historical facts. These statements are based on the
current expectations of Exela management and are not predictions of
actual performance. These statements are subject to a number of
risks and uncertainties, including without limitation the network
outage described in this press release and those discussed under
the heading “Risk Factors” in our Annual Report and in subsequent
filings with the Securities and Exchange Commission. In addition,
forward-looking statements provide Exela’s expectations, plans or
forecasts of future events and views as of the date of this
communication. Exela anticipates that subsequent events and
developments will cause Exela’s assessments to change. These
forward-looking statements should not be relied upon as
representing Exela’s assessments as of any date subsequent to the
date of this press release.
For more Exela news, commentary, and industry
perspectives, visit:
Website: https://investors.exelatech.com/
Twitter: @ExelaTech
LinkedIn: /exela-technologies
Facebook: @exelatechnologies
Instagram: @exelatechnologies
The information posted on the Company's website and/or via its
social media accounts may be deemed material to investors.
Accordingly, investors, media and others interested in the Company
should monitor the Company's website and its social media accounts
in addition to the Company's press releases, SEC filings
and public conference calls and webcasts.
Investor and/or Media
Contacts:Vincent KondaveetiE:
vincent.kondaveeti@exelatech.com
Mary Beth BenjaminE: IR@exelatech.com
Source: Exela Technologies, Inc.
|
Exela
Technologies, Inc. and Subsidiaries |
Condensed
Consolidated Balance Sheets |
As of
September 30, 2022 and December 31, 2021 |
(in thousands of
United States dollars except share and per share amounts) |
|
|
|
|
|
|
|
|
|
September 30, |
|
December 31, |
|
|
2022 |
|
2021 |
|
|
(Unaudited) |
|
(Audited) |
|
|
|
|
(Restated) |
Assets |
|
|
|
|
|
|
Current
assets |
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
10,401 |
|
|
$ |
20,775 |
|
Restricted
cash |
|
|
34,402 |
|
|
|
27,285 |
|
Accounts
receivable, net of allowance for doubtful accounts of $5,930 and
$6,049, respectively |
|
|
93,600 |
|
|
|
184,102 |
|
Related
party receivables and prepaid expenses |
|
|
504 |
|
|
|
715 |
|
Inventories,
net |
|
|
17,234 |
|
|
|
15,215 |
|
Prepaid
expenses and other current assets |
|
|
28,551 |
|
|
|
31,799 |
|
Total current assets |
|
|
184,692 |
|
|
|
279,891 |
|
Property,
plant and equipment, net of accumulated depreciation of $201,650
and $196,683, respectively |
|
|
68,788 |
|
|
|
73,449 |
|
Operating
lease right-of-use assets, net |
|
|
44,943 |
|
|
|
53,937 |
|
Goodwill |
|
|
328,071 |
|
|
|
358,323 |
|
Intangible
assets, net |
|
|
211,659 |
|
|
|
244,539 |
|
Deferred
income tax assets |
|
|
1,279 |
|
|
|
2,109 |
|
Other
noncurrent assets |
|
|
25,839 |
|
|
|
24,775 |
|
Total assets |
|
$ |
865,271 |
|
|
$ |
1,037,023 |
|
|
|
|
|
|
|
|
Liabilities and Stockholders' Equity
(Deficit) |
|
|
|
|
|
|
Liabilities |
|
|
|
|
|
|
Current
liabilities |
|
|
|
|
|
|
Accounts
payable |
|
$ |
80,783 |
|
|
$ |
61,744 |
|
Related
party payables |
|
|
1,698 |
|
|
|
1,484 |
|
Income tax
payable |
|
|
1,178 |
|
|
|
3,551 |
|
Accrued
liabilities |
|
|
52,795 |
|
|
|
113,519 |
|
Accrued
compensation and benefits |
|
|
52,925 |
|
|
|
60,860 |
|
Accrued
interest |
|
|
29,430 |
|
|
|
10,075 |
|
Customer
deposits |
|
|
18,278 |
|
|
|
17,707 |
|
Deferred
revenue |
|
|
15,681 |
|
|
|
16,617 |
|
Obligation
for claim payment |
|
|
50,780 |
|
|
|
46,902 |
|
Current
portion of finance lease liabilities |
|
|
4,902 |
|
|
|
6,683 |
|
Current
portion of operating lease liabilities |
|
|
13,127 |
|
|
|
15,923 |
|
Current
portion of long-term debts |
|
|
195,043 |
|
|
|
236,775 |
|
Total current liabilities |
|
|
516,620 |
|
|
|
591,840 |
|
Long-term
debt, net of current maturities |
|
|
909,506 |
|
|
|
1,012,452 |
|
Finance
lease liabilities, net of current portion |
|
|
7,276 |
|
|
|
9,156 |
|
Pension
liabilities, net |
|
|
23,165 |
|
|
|
28,383 |
|
Deferred
income tax liabilities |
|
|
14,046 |
|
|
|
11,594 |
|
Long-term
income tax liabilities |
|
|
2,757 |
|
|
|
3,201 |
|
Operating
lease liabilities, net of current portion |
|
|
34,573 |
|
|
|
41,170 |
|
Other
long-term liabilities |
|
|
4,888 |
|
|
|
5,999 |
|
Total liabilities |
|
|
1,512,831 |
|
|
|
1,703,795 |
|
Commitments
and Contingencies (Note 8) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders' equity (deficit) |
|
|
|
|
|
|
Common
Stock, par value of $0.0001 per share; 1,600,000,000 shares
authorized; 80,173,342 shares issued and 80,050,757 shares
outstanding at September 30, 2022 and 13,382,333 shares issued and
13,259,748 shares outstanding at December 31, 2021 |
|
|
142 |
|
|
|
37 |
|
Preferred
stock, $0.0001 par value per share, 20,000,000 shares authorized at
September 30, 2022 and December 31, 2021, respectively |
|
|
|
|
|
|
Series A Preferred Stock, 2,778,111 shares issued and outstanding
at September 30, 2022 and December 31, 2021 |
|
|
1 |
|
|
|
1 |
|
Series B Preferred Stock, 3,029,900 shares issued and outstanding
at September 30, 2022 and 0 shares issued and outstanding at
December 31, 2021 |
|
|
- |
|
|
|
- |
|
Additional
paid in capital |
|
|
1,072,322 |
|
|
|
838,853 |
|
Less: Common
Stock held in treasury, at cost; 122,585 shares at September 30,
2022 and December 31, 2021 |
|
|
(10,949 |
) |
|
|
(10,949 |
) |
Equity-based
compensation |
|
|
56,676 |
|
|
|
56,123 |
|
Accumulated
deficit |
|
|
(1,753,865 |
) |
|
|
(1,532,428 |
) |
Accumulated
other comprehensive loss: |
|
|
|
|
|
|
Foreign
currency translation adjustment |
|
|
(2,875 |
) |
|
|
(7,463 |
) |
Unrealized
pension actuarial losses, net of tax |
|
|
(9,012 |
) |
|
|
(10,946 |
) |
Total
accumulated other comprehensive loss |
|
|
(11,887 |
) |
|
|
(18,409 |
) |
Total stockholders' deficit |
|
|
(647,560 |
) |
|
|
(666,772 |
) |
Total liabilities and stockholders' deficit |
|
$ |
865,271 |
|
|
$ |
1,037,023 |
|
|
|
|
|
|
|
|
|
|
|
Exela
Technologies, Inc. and Subsidiaries |
Condensed
Consolidated Statements of Operations |
For the
three and nine months ended September 30, 2022 and
2021 |
(in thousands of
United States dollars except share and per share amounts) |
(Unaudited) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended September 30, |
|
Nine Months Ended September 30, |
|
|
2022 |
|
2021 |
|
2022 |
|
2021 |
Revenue |
|
$ |
264,038 |
|
|
$ |
279,229 |
|
|
$ |
810,206 |
|
|
$ |
872,294 |
|
Cost of
revenue (exclusive of depreciation and amortization) |
|
|
217,842 |
|
|
|
211,731 |
|
|
|
658,623 |
|
|
|
653,398 |
|
Selling,
general and administrative expenses (exclusive of depreciation and
amortization) |
|
|
44,369 |
|
|
|
43,244 |
|
|
|
137,604 |
|
|
|
121,519 |
|
Depreciation
and amortization |
|
|
17,737 |
|
|
|
19,094 |
|
|
|
53,942 |
|
|
|
58,113 |
|
Impairment
of goodwill and other intangible assets |
|
|
29,565 |
|
|
|
- |
|
|
|
29,565 |
|
|
|
- |
|
Related
party expense |
|
|
2,016 |
|
|
|
2,744 |
|
|
|
6,189 |
|
|
|
7,199 |
|
Operating profit (loss) |
|
|
(47,491 |
) |
|
|
2,416 |
|
|
|
(75,717 |
) |
|
|
32,065 |
|
Other expense (income), net: |
|
|
|
|
|
|
|
|
|
|
|
|
Interest
expense, net |
|
|
40,897 |
|
|
|
41,757 |
|
|
|
122,928 |
|
|
|
127,755 |
|
Debt
modification and extinguishment costs (gain), net |
|
|
(4,696 |
) |
|
|
(28,070 |
) |
|
|
4,305 |
|
|
|
(28,070 |
) |
Sundry
expense (income), net |
|
|
781 |
|
|
|
136 |
|
|
|
347 |
|
|
|
(438 |
) |
Other
expense (income), net |
|
|
(1,115 |
) |
|
|
366 |
|
|
|
12,419 |
|
|
|
1,169 |
|
Net
loss before income taxes |
|
|
(83,358 |
) |
|
|
(11,773 |
) |
|
|
(215,716 |
) |
|
|
(68,351 |
) |
Income tax expense |
|
|
(1,924 |
) |
|
|
(1,441 |
) |
|
|
(5,721 |
) |
|
|
(3,430 |
) |
Net
loss |
|
$ |
(85,282 |
) |
|
$ |
(13,214 |
) |
|
$ |
(221,437 |
) |
|
$ |
(71,781 |
) |
Dividend equivalent on Series A Preferred Stock related to
beneficial conversion feature |
|
|
|
|
|
|
|
Cumulative
dividends for Series A Preferred Stock |
|
|
(908 |
) |
|
|
(822 |
) |
|
|
(2,648 |
) |
|
|
(724 |
) |
Cumulative
dividends for Series B Preferred Stock |
|
|
(1,136 |
) |
|
|
- |
|
|
|
(2,528 |
) |
|
|
- |
|
Net
loss attributable to common stockholders |
|
$ |
(87,326 |
) |
|
$ |
(14,036 |
) |
|
$ |
(226,613 |
) |
|
$ |
(72,505 |
) |
Loss
per share: |
|
|
|
|
|
|
|
|
|
|
|
|
Basic and
diluted |
|
$ |
(1.38 |
) |
|
$ |
(1.86 |
) |
|
$ |
(6.41 |
) |
|
$ |
(16.49 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exela
Technologies, Inc. and Subsidiaries |
Condensed
Consolidated Statement of Cash Flows |
For the nine
months ended September 30, 2022 and 2021 |
(in thousands of
United States dollars except share and per share amounts) |
(Unaudited) |
|
|
|
|
|
|
|
|
|
Nine Months Ended September 30, |
|
|
2022 |
|
2021 |
Cash
flows from operating activities |
|
|
|
|
|
|
Net loss |
|
$ |
(221,437 |
) |
|
$ |
(71,781 |
) |
Adjustments
to reconcile net loss |
|
|
|
|
|
|
Depreciation
and amortization |
|
|
53,942 |
|
|
|
58,113 |
|
Original
issue discount and debt issuance cost amortization |
|
|
10,383 |
|
|
|
11,684 |
|
Debt
modification and extinguishment costs (gain), net |
|
|
(1,803 |
) |
|
|
(28,070 |
) |
Impairment
of goodwill and other intangible assets |
|
|
29,565 |
|
|
|
- |
|
Provision
for doubtful accounts |
|
|
704 |
|
|
|
2,427 |
|
Deferred
income tax provision |
|
|
2,492 |
|
|
|
484 |
|
Share-based
compensation expense |
|
|
694 |
|
|
|
1,519 |
|
Unrealized
foreign currency losses |
|
|
(1,503 |
) |
|
|
(604 |
) |
Loss (Gain)
on sale of assets |
|
|
548 |
|
|
|
(112 |
) |
Fair value
adjustment for interest rate swap |
|
|
- |
|
|
|
(125 |
) |
Change in
operating assets and liabilities, net of effect from
acquisitions |
|
|
|
|
|
|
Accounts receivable |
|
|
83,282 |
|
|
|
14,440 |
|
Prepaid expenses and other assets |
|
|
(6,910 |
) |
|
|
(4,329 |
) |
Accounts payable and accrued liabilities |
|
|
(37,004 |
) |
|
|
(57,433 |
) |
Related party payables |
|
|
426 |
|
|
|
604 |
|
Additions to outsource contract costs |
|
|
(330 |
) |
|
|
(405 |
) |
Net cash used in operating activities |
|
|
(86,951 |
) |
|
|
(73,588 |
) |
|
|
|
|
|
|
|
Cash
flows from investing activities |
|
|
|
|
|
|
Purchase of
property, plant and equipment |
|
|
(14,208 |
) |
|
|
(6,950 |
) |
Additions to
patents |
|
|
(15 |
) |
|
|
- |
|
Additions to
internally developed software |
|
|
(2,710 |
) |
|
|
(951 |
) |
Proceeds
from sale of assets |
|
|
194 |
|
|
|
4,252 |
|
Net cash used in investing activities |
|
|
(16,739 |
) |
|
|
(3,649 |
) |
|
|
|
|
|
|
|
Cash
flows from financing activities |
|
|
|
|
|
|
Proceeds
from issuance of Common Stock from private placement |
|
|
- |
|
|
|
25,065 |
|
Proceeds
from issuance of Common Stock from at the market offerings |
|
|
245,073 |
|
|
|
249,169 |
|
Dividend
paid on Series B Preferred Stock |
|
|
(2,532 |
) |
|
|
- |
|
Repurchases
of Common Stock for retirement |
|
|
(487 |
) |
|
|
- |
|
Cash paid
for equity issuance costs from at the market offerings |
|
|
(8,480 |
) |
|
|
(9,060 |
) |
Borrowings
under factoring arrangement and Securitization Facility |
|
|
93,867 |
|
|
|
102,141 |
|
Principal
repayment on borrowings under factoring arrangement and
Securitization Facility |
|
|
(186,245 |
) |
|
|
(105,112 |
) |
Cash paid
for withholding taxes on vested RSUs |
|
|
(138 |
) |
|
|
- |
|
Lease
terminations |
|
|
3 |
|
|
|
(125 |
) |
Cash paid
for debt issuance costs |
|
|
(7,125 |
) |
|
|
- |
|
Principal
payments on finance lease obligations |
|
|
(4,342 |
) |
|
|
(8,446 |
) |
Borrowings
from senior secured revolving facility and BRCC revolver |
|
|
20,000 |
|
|
|
3,000 |
|
Repayments
on senior secured revolving facility |
|
|
(49,477 |
) |
|
|
(55 |
) |
Proceeds
from issuance of 2026 Notes |
|
|
80,620 |
|
|
|
- |
|
Borrowings
from other loans |
|
|
7,500 |
|
|
|
8,537 |
|
Cash paid
for debt repurchases |
|
|
(4,712 |
) |
|
|
(58,607 |
) |
Repayment of
BRCC term loan |
|
|
(59,209 |
) |
|
|
- |
|
Principal
repayments on senior secured term loans and other loans |
|
|
(22,829 |
) |
|
|
(28,512 |
) |
Net cash provided by financing activities |
|
|
101,487 |
|
|
|
177,995 |
|
Effect of
exchange rates on cash |
|
|
(1,054 |
) |
|
|
(78 |
) |
Net increase (decrease) in cash and cash
equivalents |
|
|
(3,257 |
) |
|
|
100,680 |
|
Cash,
restricted cash, and cash equivalents |
|
|
|
|
|
|
Beginning of
period |
|
|
48,060 |
|
|
|
70,309 |
|
End of
period |
|
$ |
44,803 |
|
|
$ |
170,989 |
|
Supplemental cash flow data: |
|
|
|
|
|
|
Income tax
payments, net of refunds received |
|
$ |
5,267 |
|
|
$ |
2,766 |
|
Interest
paid |
|
|
93,405 |
|
|
|
137,862 |
|
Noncash investing and financing activities: |
|
|
|
|
|
|
Assets
acquired through right-of-use arrangements |
|
|
958 |
|
|
|
2,754 |
|
Leasehold
improvements funded by lessor |
|
|
- |
|
|
|
125 |
|
Accrued
capital expenditures |
|
|
1,916 |
|
|
|
2,495 |
|
|
|
|
|
|
|
|
|
|
|
Exela
TechnologiesSchedule
1: Third Quarter 2022
vs. Third Quarter
2021Financial
Performance(Unaudited) |
|
|
|
|
|
|
|
|
|
$ in million |
Q3-2022 |
Q3-2021 |
Increase (Decrease) YoY ($ mn) |
Increase (Decrease) YoY (%) |
|
Q2-2022 |
Increase (Decrease) QoQ ($ mn) |
Increase (Decrease) QoQ (%) |
|
|
|
|
|
|
|
|
|
Information and Transaction Processing Solutions |
185.3 |
|
208.3 |
|
(23.0 |
) |
(11.0%) |
|
190.0 |
|
(4.7 |
) |
(2.5%) |
Healthcare
Solutions |
61.0 |
|
54.0 |
|
7.0 |
|
13.0% |
|
56.4 |
|
4.6 |
|
8.2% |
Legal and
Loss Prevention Services |
17.8 |
|
16.9 |
|
0.9 |
|
5.3% |
|
20.4 |
|
(2.6 |
) |
(12.7%) |
Total Revenue |
264.0 |
|
279.2 |
|
(15.2 |
) |
-5.4% |
|
266.8 |
|
(2.7 |
) |
-1.0% |
|
|
|
|
|
|
|
|
|
Gross
profit |
46.2 |
|
67.5 |
|
(21.3 |
) |
(31.6%) |
|
49.5 |
|
(3.3 |
) |
(6.7%) |
Gross profit margin |
17.5% |
|
24.2% |
|
(6.7% |
) |
-668 bps |
|
18.6% |
|
(1.1% |
) |
-106 bps |
|
|
|
|
|
|
|
|
|
SG&A |
44.4 |
|
43.2 |
|
1.1 |
|
2.6% |
|
50.2 |
|
(5.8 |
) |
(11.6%) |
|
|
|
|
|
|
|
|
|
Operating
(loss) income |
(47.5 |
) |
2.4 |
|
(49.9 |
) |
(2066.1%) |
|
(20.9 |
) |
(26.6 |
) |
127.4% |
Operating margin |
(18.0% |
) |
0.9% |
|
(18.9% |
) |
-1885 bps |
|
(7.8% |
) |
(10.2% |
) |
-1016 bps |
|
|
|
|
|
|
|
|
|
Net income
(loss) |
(85.3 |
) |
(13.2 |
) |
(72.1 |
) |
545.4% |
|
(79.2 |
) |
(6.1 |
) |
7.7% |
Net income margin |
(32.3% |
) |
(4.7% |
) |
(27.6% |
) |
-2757 bps |
|
(29.7% |
) |
(2.6% |
) |
-261 bps |
|
|
|
|
|
|
|
|
|
EBITDA |
(24.7 |
) |
49.1 |
|
(73.8 |
) |
(150.4%) |
|
(17.6 |
) |
(7.1 |
) |
40.2% |
EBITDA Margin |
(9.4% |
) |
17.6% |
|
(26.9% |
) |
-2694 bps |
|
(6.6% |
) |
(2.8% |
) |
-275 bps |
|
|
|
|
|
|
|
|
|
Adjusted EBITDA |
31.8 |
|
36.4 |
|
(4.6 |
) |
-12.5% |
|
36.5 |
|
(4.6 |
) |
-12.7% |
Adjusted EBITDA margin |
12.1% |
|
13.0% |
|
(1.0% |
) |
-98 bps |
|
13.7% |
|
(1.6% |
) |
-161 bps |
|
|
|
|
|
|
|
|
|
|
Exela
TechnologiesSchedule 2: Reconciliation of Adjusted
EBITDA and constant currency revenues |
|
|
|
|
|
|
|
Reconciliation of Non-GAAP Financial Measures to GAAP
Measures |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-GAAP constant currency revenue
reconciliation |
|
|
|
|
|
|
|
|
Three months ended |
($ in
millions) |
|
30-Sep-22 |
|
30-Sep-21 |
|
30-Jun-22 |
Revenues, as reported (GAAP) |
|
$264.0 |
|
|
$279.2 |
|
|
$266.8 |
|
Foreign
currency exchange impact(1) |
|
|
7.0 |
|
|
|
|
|
6.2 |
|
Revenues, at constant currency (Non-GAAP) |
|
$271.1 |
|
|
$279.2 |
|
|
$273.0 |
|
|
|
|
|
|
|
|
(1) Constant currency
excludes the impact of foreign currency fluctuations and is
computed by applying the average exchange rates for the three
months and nine months ended September 30, 2021, to the revenues
during the corresponding period in 2022. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reconciliation of Adjusted EBITDA |
|
|
|
|
|
|
|
|
Three months ended |
($ in
millions) |
|
30-Sep-22 |
|
30-Sep-21 |
|
30-Jun-22 |
Net loss (GAAP) |
|
($85.3 |
) |
|
($13.2 |
) |
|
($79.2 |
) |
Interest expense |
|
|
40.9 |
|
|
|
41.8 |
|
|
|
42.3 |
|
Taxes |
|
|
1.9 |
|
|
|
1.4 |
|
|
|
1.3 |
|
Depreciation
and amortization |
|
|
17.7 |
|
|
|
19.1 |
|
|
|
18.0 |
|
EBITDA (Non-GAAP) |
|
($24.7 |
) |
|
$49.1 |
|
|
($17.6 |
) |
Transaction
and integration costs |
|
|
4.1 |
|
|
|
1.9 |
|
|
|
8.6 |
|
Gain / loss
on derivative instruments |
|
|
(1.1 |
) |
|
|
- |
|
|
|
- |
|
Other
Charges / (gains) |
|
|
47.2 |
|
|
|
(19.3 |
) |
|
|
38.9 |
|
Sub-Total (Adj. EBITDA before O&R) |
|
$25.6 |
|
|
$31.7 |
|
|
$29.9 |
|
Optimization
and restructuring expenses |
|
|
6.3 |
|
|
|
4.7 |
|
|
|
6.6 |
|
Adjusted EBITDA (Non-GAAP) |
|
$31.8 |
|
|
$36.4 |
|
|
$36.5 |
|
|
|
|
|
|
|
|
Exela Technologies (NASDAQ:XELAP)
Historical Stock Chart
From Feb 2025 to Mar 2025
Exela Technologies (NASDAQ:XELAP)
Historical Stock Chart
From Mar 2024 to Mar 2025